Wall Street Analysts See a 230.23% Upside in Promis Neurosciences (PMN): Can the Stock Really Move This High?

Promis Neurosciences (PMN) analyst price targets imply 230.2% upside, though the metric itself has been an unreliable indicator historically. The article notes strong analyst agreement in raising earnings estimates, which supports a modest positive skew for the stock despite the lack of proven predictive power from target levels.

Analysis

Promis Neurosciences (PMN) analyst price targets imply 230.2% upside, though the metric itself has been an unreliable indicator historically. The article notes strong analyst agreement in raising earnings estimates, which supports a modest positive skew for the stock despite the lack of proven predictive power from target levels.